Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of a metformin-containing combination regimen in refractory or relapsed acquired aplastic anemia
ChiCTR2000028833Phase 2Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in acquired aplastic anemia (AAA) and aplastic anemia (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Hemoglobin, Platelet count and 2 more. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
acquired aplastic anemia (AAA)aplastic anemia
Beyond the preview
Go deeper on ChiCTR2000028833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028833.